惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

M
MIT News - Artificial intelligence
罗磊的独立博客
Hugging Face - Blog
Hugging Face - Blog
Apple Machine Learning Research
Apple Machine Learning Research
Last Week in AI
Last Week in AI
S
SegmentFault 最新的问题
让小产品的独立变现更简单 - ezindie.com
让小产品的独立变现更简单 - ezindie.com
美团技术团队
人人都是产品经理
人人都是产品经理
WordPress大学
WordPress大学
The Cloudflare Blog
IT之家
IT之家
雷峰网
雷峰网
小众软件
小众软件
博客园 - 叶小钗
博客园 - 聂微东
爱范儿
爱范儿
博客园 - 司徒正美
博客园 - 三生石上(FineUI控件)
V
Visual Studio Blog
博客园 - 【当耐特】
V
V2EX
博客园_首页
T
Tailwind CSS Blog

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Bio-Rad Laboratories, Inc. (BIO) Q1 2026 Earnings Call Tr...
SA Transcripts · 2026-05-01 · via All Articles on Seeking Alpha

Q1: 2026-04-30 Earnings Summary

EPS of $1.89 misses by $0.10

 | Revenue of $592.10M (1.14% Y/Y) beats by $3.24M

Bio-Rad Laboratories, Inc. (BIO) Q1 2026 Earnings Call April 30, 2026 5:00 PM EDT

Company Participants

Ruben Argueta
Jonathan DiVincenzo - President & COO
Roop Lakkaraju - Executive VP & CFO
Norman Schwartz - Chairman & CEO

Conference Call Participants

Jack Meehan - Nephron Research LLC
Brandon Couillard - Wells Fargo Securities, LLC, Research Division
Tycho Peterson - Jefferies LLC, Research Division
Patrick Donnelly - Citigroup Inc. Exchange Research
Daniel Leonard

Presentation

Operator

Ladies and gentlemen, thank you for standing by. My name is Regina, and I will be your conference operator today. At this time, I would like to welcome everyone to Bio-Rad's First Quarter 2026 Results Conference Call and Webcast. [Operator Instructions] I would now like to turn the conference over to Ruben Argueta, Bio-Rad's Head of Investor Relations. You may begin.

Ruben Argueta

Thank you, Regina. Good afternoon, everyone, and thank you for joining us. My name is Ruben Argueta, Bio-Rad's new Head of IR. It's a pleasure to join the team and be with you here. Today, we will review the financial results for the first quarter ended March 31, 2026, and provide an update on key business trends for Bio-Rad.

With me on the call today are Norman Schwartz, our Chief Executive Officer; Jonathan DiVincenzo, President and Chief Operating Officer; and Roop Lakkaraju, Executive Vice President and Chief Financial Officer.

Before we begin our review, I would like to remind everyone that we will be making forward-looking statements about management's goals, plans and expectations, our future financial performance and other matters. These statements are based on assumptions and expectations of future events that are subject to risks and uncertainties. Our actual results may differ materially from these plans, goals and expectations. You should not place undue reliance on these forward-looking statements, and I encourage you to review our filings with the SEC, where we discuss in detail the